159 related articles for article (PubMed ID: 17206396)
1. Serum-soluble selectin levels in patients with Behçet's disease.
Ateş A; Tiryaki OA; Olmez U; Tutkak H
Clin Rheumatol; 2007 Mar; 26(3):411-7. PubMed ID: 17206396
[TBL] [Abstract][Full Text] [Related]
2. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
3. Selectin adhesion molecules in Behçet's disease.
Haznedaroglu E; Karaaslan Y; Büyükaşik Y; Koşar A; Ozcebe O; Haznedaroglu bC; Kirazli E; Dündar SV
Ann Rheum Dis; 2000 Jan; 59(1):61-3. PubMed ID: 10627429
[TBL] [Abstract][Full Text] [Related]
4. [Soluble selectins in myocardial infarction].
Lampka M; Grabczewska Z; Krajewska M; Piskorska E; Hołyńska-Iwan I; Kubica J
Pol Merkur Lekarski; 2013 Apr; 34(202):188-91. PubMed ID: 23745322
[TBL] [Abstract][Full Text] [Related]
5. [Concentration of soluble forms of selectins in serum and in cerebrospinal fluid in group of patients with neuroborreliosis--a preliminary study].
Moniuszko AM; Pancewicz SA; Kondrusik M; Zajkowska J; Grygorczuk S; Swierzbińska R
Pol Merkur Lekarski; 2007 Sep; 23(135):174-8. PubMed ID: 18080689
[TBL] [Abstract][Full Text] [Related]
6. Levels of soluble E-selectin in patients with active Behçet's disease.
Sari RA; Kiziltunç A; Tays'y S; Akdem'yr S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 27520409
[TBL] [Abstract][Full Text] [Related]
7. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
8. Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis.
Ateş A; Kinikli G; Turgay M; Duman M
Scand J Immunol; 2004 Mar; 59(3):315-20. PubMed ID: 15030584
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
[TBL] [Abstract][Full Text] [Related]
10. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
11. [A study of soluble form of selectin family in the sera of patients with neuroimmunological disorders].
Sakai T; Inoue A; Koh CS; Yamazaki M; Yanagisawa N
Rinsho Shinkeigaku; 1998 Mar; 38(3):197-202. PubMed ID: 9711113
[TBL] [Abstract][Full Text] [Related]
12. L and E selectins in acute myeloid leukemia: expression, clinical relevance and relation to patient outcome.
Aref S; Salama O; Al-Tonbary Y; Fouda M; Menessy A; El-Sherbiny M
Hematology; 2002 Apr; 7(2):83-7. PubMed ID: 12186696
[TBL] [Abstract][Full Text] [Related]
13. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
14. Role of Serum miR-181b, Proinflammatory Cytokine, and Adhesion Molecules in Behçet's Disease.
El Boghdady NA; Shaker OG
J Interferon Cytokine Res; 2019 Jun; 39(6):347-354. PubMed ID: 30848985
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet's disease.
Kato Y; Yamamoto T
Int J Dermatol; 2012 Mar; 51(3):286-9. PubMed ID: 22348563
[TBL] [Abstract][Full Text] [Related]
16. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
[TBL] [Abstract][Full Text] [Related]
17. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
[TBL] [Abstract][Full Text] [Related]
18. Prolactin levels in Behçet's disease: no correlation with disease manifestations and activity.
Houman H; Ben Ghorbel I; Lamloum M; Feki M; Khanfir M; Mebazaa A; Miled M
Ann Med Interne (Paris); 2001 Apr; 152(3):209-11. PubMed ID: 11431583
[TBL] [Abstract][Full Text] [Related]
19. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
[TBL] [Abstract][Full Text] [Related]
20. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease.
Çerçi P; Altıner S; İnal A; Köse K; Keskin G; Ölmez Ü
Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
